Prescient Healthcare Group has been recognized, for the third year in a row, as one of the 50 fastest-growing privately owned pharma companies in the UK.
Companies in the Alantra Pharma Fast 50 are passionate about the potential of their businesses to deliver lasting societal change, determined to innovate, and ambitious about what they can achieve, whether commercially or scientifically. They offer the industry – and the world – a brighter future.
Prescient brings evidence-based design thinking and decision making to clinical and commercial strategy, ensuring the scientific potential of a molecule is optimally translated into a value proposition that resonates with stakeholders as relevant, differentiated and meaningful.
Prescient has ranked 28th overall and 6th in the category.
To view the full report, please click here.